IS4725A - Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa - Google Patents
Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasaInfo
- Publication number
- IS4725A IS4725A IS4725A IS4725A IS4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A IS 4725 A IS4725 A IS 4725A
- Authority
- IS
- Iceland
- Prior art keywords
- amidine
- derivatives
- nitric oxide
- oxide synthase
- inhibit nitric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Exhaust Gas Treatment By Means Of Catalyst (AREA)
- Treating Waste Gases (AREA)
- Gas Separation By Absorption (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US625395P | 1995-11-07 | 1995-11-07 | |
US627695P | 1995-11-07 | 1995-11-07 | |
SE9600275A SE9600275D0 (sv) | 1996-01-25 | 1996-01-25 | Compounds |
SE9603301A SE9603301D0 (sv) | 1996-09-11 | 1996-09-11 | Compounds and compositions |
SE9603300A SE9603300D0 (sv) | 1996-09-11 | 1996-09-11 | Compounds |
PCT/SE1996/001425 WO1997017344A1 (en) | 1995-11-07 | 1996-11-06 | Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
Publications (1)
Publication Number | Publication Date |
---|---|
IS4725A true IS4725A (is) | 1998-04-24 |
Family
ID=27532790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS4725A IS4725A (is) | 1995-11-07 | 1998-04-24 | Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0861250B1 (is) |
JP (1) | JP2000500132A (is) |
KR (1) | KR19990067349A (is) |
AT (1) | ATE213241T1 (is) |
AU (1) | AU701329B2 (is) |
BR (1) | BR9611276A (is) |
CA (1) | CA2235301A1 (is) |
CZ (1) | CZ139298A3 (is) |
DE (1) | DE69619259T2 (is) |
DK (1) | DK0861250T3 (is) |
EE (1) | EE9800141A (is) |
ES (1) | ES2171743T3 (is) |
HU (1) | HUP9900142A3 (is) |
IL (1) | IL124296A0 (is) |
IS (1) | IS4725A (is) |
NO (1) | NO982072L (is) |
NZ (1) | NZ322227A (is) |
PL (1) | PL326554A1 (is) |
PT (1) | PT861250E (is) |
SI (1) | SI0861250T1 (is) |
SK (1) | SK61098A3 (is) |
TR (1) | TR199800813T2 (is) |
TW (1) | TW458978B (is) |
WO (1) | WO1997017344A1 (is) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016526A1 (en) * | 1996-10-16 | 1998-04-23 | Glaxo Group Limited | Tetrahydro-6h-pyrazino[1,2-b]isoquinoline 1,4-diones as apoprotein b-100 inhibitors |
SE9701681D0 (sv) | 1997-05-05 | 1997-05-05 | Astra Ab | New compounds |
SE9901901D0 (sv) * | 1999-05-26 | 1999-05-26 | Astra Ab | Compounds |
NZ533358A (en) * | 2001-12-19 | 2007-05-31 | Lundbeck & Co As H | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists |
US6608193B2 (en) * | 2001-12-21 | 2003-08-19 | The Procter & Gamble Company | Methods for synthesis of amino-tetrahydroisoquinoline ring compounds |
JP4664673B2 (ja) * | 2002-08-07 | 2011-04-06 | ニューラクソン インコーポレイテッド | Nos阻害活性を有するアミノベンゾチアゾール化合物 |
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
CN101258135A (zh) * | 2005-07-05 | 2008-09-03 | 阿斯利康(瑞典)有限公司 | 新化合物、其制备方法、中间体、药物组合物和其在治疗5-ht6介导的疾病例如阿尔茨海默病、认知障碍、精神分裂症相关的认知缺损、肥胖和帕金森病中的用途 |
JP5497429B2 (ja) | 2007-03-07 | 2014-05-21 | 武田薬品工業株式会社 | ベンゾオキサゼピン誘導体およびその用途 |
KR102480808B1 (ko) | 2016-12-23 | 2022-12-22 | 다이이찌 산쿄 가부시키가이샤 | Tnap 저해 활성을 갖는 술폰아미드 화합물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09504278A (ja) * | 1944-06-01 | 1997-04-28 | ザ、ウェルカム、ファンデーション、リミテッド | Noシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体 |
EP0690851B1 (en) * | 1993-03-23 | 1999-05-19 | Astra Aktiebolag | Guanidine derivatives useful in therapy |
HUT75876A (en) * | 1993-08-12 | 1997-05-28 | Astra Ab | Amidine derivatives with nitric oxide synthetase activities, pharmaceutical compositions containing them and process for their preparation |
TW397812B (en) * | 1995-02-11 | 2000-07-11 | Astra Ab | Bicyclic isothiourea derivatives useful in therapy |
-
1996
- 1996-10-30 TW TW085113282A patent/TW458978B/zh active
- 1996-11-06 BR BR9611276A patent/BR9611276A/pt not_active Application Discontinuation
- 1996-11-06 TR TR1998/00813T patent/TR199800813T2/xx unknown
- 1996-11-06 PT PT96938584T patent/PT861250E/pt unknown
- 1996-11-06 CA CA002235301A patent/CA2235301A1/en not_active Abandoned
- 1996-11-06 KR KR1019980703356A patent/KR19990067349A/ko not_active Application Discontinuation
- 1996-11-06 JP JP9518124A patent/JP2000500132A/ja active Pending
- 1996-11-06 DE DE69619259T patent/DE69619259T2/de not_active Expired - Fee Related
- 1996-11-06 AU AU75927/96A patent/AU701329B2/en not_active Ceased
- 1996-11-06 WO PCT/SE1996/001425 patent/WO1997017344A1/en not_active Application Discontinuation
- 1996-11-06 ES ES96938584T patent/ES2171743T3/es not_active Expired - Lifetime
- 1996-11-06 NZ NZ322227A patent/NZ322227A/xx unknown
- 1996-11-06 PL PL96326554A patent/PL326554A1/xx unknown
- 1996-11-06 EP EP96938584A patent/EP0861250B1/en not_active Expired - Lifetime
- 1996-11-06 SK SK610-98A patent/SK61098A3/sk unknown
- 1996-11-06 AT AT96938584T patent/ATE213241T1/de not_active IP Right Cessation
- 1996-11-06 IL IL12429696A patent/IL124296A0/xx unknown
- 1996-11-06 DK DK96938584T patent/DK0861250T3/da active
- 1996-11-06 EE EE9800141A patent/EE9800141A/xx unknown
- 1996-11-06 CZ CZ981392A patent/CZ139298A3/cs unknown
- 1996-11-06 HU HU9900142A patent/HUP9900142A3/hu unknown
- 1996-11-06 SI SI9630451T patent/SI0861250T1/xx unknown
-
1998
- 1998-04-24 IS IS4725A patent/IS4725A/is unknown
- 1998-05-06 NO NO982072A patent/NO982072L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1997017344A1 (en) | 1997-05-15 |
ATE213241T1 (de) | 2002-02-15 |
SI0861250T1 (en) | 2002-06-30 |
TW458978B (en) | 2001-10-11 |
IL124296A0 (en) | 1998-12-06 |
ES2171743T3 (es) | 2002-09-16 |
CZ139298A3 (cs) | 1998-09-16 |
DE69619259T2 (de) | 2002-09-19 |
HUP9900142A3 (en) | 2001-08-28 |
EP0861250A1 (en) | 1998-09-02 |
MX9803453A (es) | 1998-09-30 |
DK0861250T3 (da) | 2002-04-29 |
HUP9900142A2 (hu) | 1999-05-28 |
NO982072L (no) | 1998-07-03 |
AU701329B2 (en) | 1999-01-28 |
JP2000500132A (ja) | 2000-01-11 |
EP0861250B1 (en) | 2002-02-13 |
CA2235301A1 (en) | 1997-05-15 |
DE69619259D1 (de) | 2002-03-21 |
SK61098A3 (en) | 1999-01-11 |
KR19990067349A (ko) | 1999-08-16 |
BR9611276A (pt) | 1999-01-26 |
AU7592796A (en) | 1997-05-29 |
TR199800813T2 (xx) | 1998-07-21 |
NO982072D0 (no) | 1998-05-06 |
PL326554A1 (en) | 1998-09-28 |
EE9800141A (et) | 1998-10-15 |
NZ322227A (en) | 1999-11-29 |
PT861250E (pt) | 2002-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5031285A1 (es) | Triarilimidazoles | |
DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
SE9803518D0 (sv) | Novel compounds | |
FI934298A (fi) | Kristallin tiagabine-hydrokloridmonohydrat, dess framstaellning och dess anvaendning | |
IS4725A (is) | Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa | |
DK0634396T3 (da) | Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer | |
DK624989A (da) | Makrolidforbindelser | |
MXPA99009882A (es) | Derivados de amidina como inhibidores de la oxidonitrico sintasa. | |
DK0533516T3 (da) | Hidtil ukendte 1-(alkoxybenzyl)piperazinamidforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
SE9901901D0 (sv) | Compounds | |
SE9904676D0 (sv) | Novel compounds | |
ES2095431T3 (es) | N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
AU7935887A (en) | Therapeutic agent for the treatment of peptic ulcer disease | |
NZ501982A (en) | N-oxide forms of 2,4,4-trisubstituted-1,3-dioxolane as anti-fungal agents | |
SE9904677D0 (sv) | Novel compounds | |
SE9802650D0 (sv) | Compounds | |
WO2001058867A3 (en) | Novel compounds | |
DK0777471T3 (da) | Inhibering af leukotrienbiosynese med urinstofderivater |